Search results

Articles (7)

Journals (0)

1-7 of 7 results for second-generation androgen receptor antagonists

Sort by:

Relevance

Select all

Sort by:

Relevance

Retricted access

Research article

First published 2024

Falls and fractures in men with prostate cancer taking second-generation androgen receptor antagonists: A retrospective chart review

Morgan Dennison, Lisa Holle

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2023-11

Updates in the Treatment of Non-Metastatic Castrate-Resistant Prostate Cancer: The Benefit of Second-Generation Androgen Receptor Antagonists

Matthew J. Hadfield, Vikram Lyall, Lisa M. Holle [...]

Annals of Pharmacotherapy

Retricted access

Review article

First published 2014-4

Enzalutamide (Xtandi) for Patients With Metastatic,Resistant Prostate Cancer

Lunawati L. Bennett, April Ingason

Annals of Pharmacotherapy

Open access

Review article

First published 2013

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Joelle El-Amm, Nihar Patel, Ashley Freeman [...]

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2016-05

Development and Implementation of a High-Throughput High-Content Screening Assay to Identify Inhibitors of Androgen Receptor Nuclear Localization in Castration-Resistant Prostate Cancer Cells

Paul A. Johnston, Minh M. Nguyen, Javid A. Dar [...]

ASSAY and Drug Development Technologies

Open access

Review article

First published 2018-12

Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials

Vadim S. Koshkin, Eric J. Small

Therapeutic Advances in Urology

Retricted access

Case report

First published 2025-12

Rhabdomyolysis induced by darolutamide and rosuvastatin

EH Lee, NE Gogolin, MM Charpentier

Journal of Oncology Pharmacy Practice